Leibniz Institute for Molecular Pharmacology (FMP)
The FMP makes contributions of fundamental significance in the field of molecular pharmacology. FMP research focusses on the structures, functions and interactions of proteins and on the development of new concepts for interfering pharmacologically with their functions. This places the research activity of the institute at the forefront of drug development. An interdisciplinary approach is crucial to this type of work, and a particular strength of the FMP is the close interaction in the fields of chemistry and biology.
Address
Leibniz Institute for Molecular Pharmacology (FMP)
Robert-Rössle-Str. 10
13125 Berlin
Berlin
Phone: +49-(0)30/94793 - 102
Fax: +49-(0)30/94793 - 109
E-mail: maul(@)fmp-berlin.de
Mandate:
national
Activities:
- Research
Networks:
- Leibniz-Gemeinschaft (WGL)
Involved in research projects:
- Detection and analysis of hepatotoxic modes of action for the prediction of carcinogenic effects of chemicals in the subacute toxicity test (repeated dose 28-day oral toxicity study/ OECD TG 407) Details of Detection and analysis of hepatotoxic modes of action for the prediction of carcinogenic effects of chemicals in the subacute toxicity test (repeated dose 28-day oral toxicity study/ OECD TG 407)
- Proteomanalyses of different liver tumors of mice with activating mutations in the oncogenes ß-Catenin, Ha-Ras and B-Raf Details of Proteomanalyses of different liver tumors of mice with activating mutations in the oncogenes ß-Catenin, Ha-Ras and B-Raf
- Identification and prevalidation of hepatocellular biomarkers for detection and prediction of carci-nogenic effects of chemicals (part 1) Details of Identification and prevalidation of hepatocellular biomarkers for detection and prediction of carci-nogenic effects of chemicals (part 1)
- Application of 2-DE-based proteomics for biomarker detection in human plasma Details of Application of 2-DE-based proteomics for biomarker detection in human plasma
- Application of 2-DE-based proteomics in vitro Details of Application of 2-DE-based proteomics in vitro
- Identification of protein-biomarkers in human- and mouse-plasma after exposure to Dioxin. Details of Identification of protein-biomarkers in human- and mouse-plasma after exposure to Dioxin.
- Development and use of catalysts for oxidation of low-molecular carbohydrates 1: Screening of catalysts and testing Details of Development and use of catalysts for oxidation of low-molecular carbohydrates 1: Screening of catalysts and testing